IFNG and neoplasm: Both treatments (RT + Trp1 + αCTLA-4 and GVAX + Trp1 + αCTLA-4) induced high levels of T-bet and IFN-γ by tumor-infiltrating Trp1 cells (Figure 1B), suggesting acquisition of a Th1-like differentiation program.